| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.009 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |